Check-Cap Ltd. (CHEK) Stock Analysis & Investment Frameworks
Check-Cap Ltd. (CHEK) stock analysis on Invetso. Review Check-Cap Ltd.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Check-Cap Ltd. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: IL
Check-Cap Ltd. Key Financial Metrics
- Market Cap: $10.88M
- Revenue: $N/A
- ROE: -226.19%
- ROIC: 1974.81%
- Dividend Yield: N/A
About Check-Cap Ltd.
Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-rays. This technology is designed to thoroughly examine the internal surface of the colon, aiming to identify precancerous polyps and other structural irregularities. The company's primary offering, the C-Scan system, is composed of three integral parts: the C-Scan Cap, an ingestible X-ray scanning capsule for detecting suspected polyps; the C-Scan Track, a disposable unit that adheres to the patient's back via biocompatible adhesive patches; and the C-Scan View software. This client/server application enables the download of procedural data from the C-Scan Track, performs detailed analysis, and generates comprehensive reports. Check-Cap Ltd. was founded in 2004 and operates from its headquarters in Isfiya, Israel.